Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
Top-ranked stocks ALL, W, BILL, TWLO and CRBU are likely to beat on the bottom line in their upcoming releases.
ALL - The Allstate Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$268.14
DETAILS
HIGH:
$319.00
LOW:
$226.00
MEDIAN:
$266.50
CONSENSUS:
$268.14
UPSIDE:
3.39%
Stock News
4 PEG-Based Value Stocks to Buy as Investors Look Beyond AI
Four value stocks stand out as investors look beyond AI, using PEG ratios, earnings growth and valuation metrics to find potential winners.
Allstate Stock: Strong Earnings and Growth Keep the Outlook Bright
ALL's improving underwriting, rising investment income, policy growth and capital returns support a brighter growth outlook.
State Farm Just Handed $5 Billion Back to Customers. Here’s What That Says About Where Car Insurance Profits Are Headed
State Farm just mailed $5 billion back to policyholders, and the move says something uncomfortable about what Progressive and Allstate are quietly doing with the same windfall.
Bank of New York Mellon Corp Takes $425.48 Million Position in The Allstate Corporation $ALL
Bank of New York Mellon Corp bought a new stake in shares of The Allstate Corporation (NYSE: ALL) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,788,200 shares of the insurance provider's stock, valued at approximately $425,484,000. Bank of
5 High ROE Stocks to Buy as Markets Sway on Intense Volatility
ALL, ANET, NLY, IT and AME stand out as high-ROE, cash-rich stocks as market volatility intensifies amid bond yield swings.
B. Metzler seel. Sohn & Co. AG Buys New Stake in The Allstate Corporation $ALL
B. Metzler seel. Sohn and Co. AG acquired a new stake in shares of The Allstate Corporation (NYSE: ALL) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 41,707 shares of the insurance provider's stock, valued at approximately $9,924,000. Other institutional investors and
This Allstate Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
July 2026 Monthly Release
NORTHBROOK, Ill., Aug. 20, 2026 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) today announced estimated catastrophe losses for the month of July of $682 million or $539 million, after-tax.
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Analog Devices, Crown Castle, ebay, EPR Properties, Etsy, Merck & Co., Shopify, TJX Companies, and More
Pre-Market Stock Futures: Futures are trading lower after a wild day on Wall Street, as stocks took off after Treasury Secretary Bessent announced the Treasury would double its current bond buyback, targeting 10- to 20-year and 20- to 30-year maturities. That sparked an initial big rally, which tapered by the close; still, all of the... Here Are Thursday's Top Wall Street Analyst Research Calls: Alphabet, Analog Devices, Crown Castle, ebay, EPR Properties, Etsy, Merck and Co., Shopify, TJX Companies, and More
3,309 Shares in The Allstate Corporation $ALL Purchased by AssuredPartners Investment Advisors LLC
AssuredPartners Investment Advisors LLC purchased a new stake in The Allstate Corporation (NYSE: ALL) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,309 shares of the insurance provider's stock, valued at approximately $787,000. Several other institutional investors have also
ALL vs. TKOMY: Which Stock Is the Better Value Option?
Investors interested in stocks from the Insurance - Property and Casualty sector have probably already heard of Allstate (ALL) and Tokio Marine Holdings Inc. (TKOMY). But which of these two stocks offers value investors a better bang for their buck right now?
Should Value Investors Buy Allstate (ALL) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Income Stocks to Buy for August 18th
HMC, HMN and ALL made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 18, 2026.
New Strong Buy Stocks for August 18th
ALGT, HMC, INSP, AII and ALL have been added to the Zacks Rank #1 (Strong Buy) List on August 18, 2026.
Barden Capital Management Inc. Purchases New Position in The Allstate Corporation $ALL
Barden Capital Management Inc. acquired a new stake in shares of The Allstate Corporation (NYSE: ALL) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 5,523 shares of the insurance provider's stock, valued at approximately $1,314,000. Allstate comprises about 1.2% of Barden
Baxter Bros Inc. Invests $1.40 Million in The Allstate Corporation $ALL
Baxter Bros Inc. bought a new stake in The Allstate Corporation (NYSE: ALL) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,884 shares of the insurance provider's stock, valued at approximately $1,400,000. A number of other institutional investors and
Allstate Prepares for Quantum Computing Arrival
Insurance company Allstate is investing in quantum computing now so that the company is ready to take advantage of the technology when it arrives, Allstate Chair, President and CEO Tom Wilson told The Wall Street Journal in a report published Friday (Aug. 14). Allstate plans to expand its quantum team that currently includes 10 people.
Allstate CEO's Message on Quantum Computing: ‘Get on the Train'
The insurance giant's chief executive says companies that ultimately want competitive advantage from quantum need to start investing in and learning about it now.
Allstate invests in the people behind every claim with new industry-leading training campus
New Allstate Claims University strengthens the expertise of 23,000 claims professionals, helping customers navigate recovery with confidence after unexpected events Key takeaways Allstate opens a state-of-the-art 33,000-square-foot Allstate Claims University campus in Dallas, investing in the expertise of the 23,000 claims professionals who support approximately 8.5 million claims each year. Through immersive training environments that recreate real-world home and auto damage scenarios, claims professionals build expertise that helps them assess damage more accurately and support customers through the recovery process with confidence.
Price Targets
Argus Downgrades Allstate (ALL) to Hold
$238.00
(was $257.62)
Kevin Heal
·
Argus Research
Allstate price target raised to $265 from $240 at Morgan Stanley
$265.00
(was $267.77)
Morgan Stanley
Allstate price target raised to $315 from $300 at Raymond James
$315.00
(was $266.31)
Raymond James
Allstate price target raised to $275 from $261 at UBS
$275.00
(was $271.07)
UBS
Allstate price target raised to $280 from $250 at Goldman Sachs
$280.00
(was $275.11)
Robert Cox
·
Goldman Sachs
Allstate downgraded to Underweight from Equal Weight at Wells Fargo
$250.00
(was $275.11)
Wells Fargo
Allstate price target raised to $300 from $275 at Roth Capital
$300.00
(was $264.59)
Roth Capital
Allstate price target raised to $226 from $213 at Barclays
$226.00
(was $264.59)
Alex Scott
·
Barclays
Allstate price target raised to $275 from $240 at Roth Capital
$275.00
(was $248.55)
Roth Capital
Allstate price target raised to $319 from $295 at BofA
$319.00
(was $240.55)
Atlantic Equities
Allstate downgraded to Neutral from Buy at UBS
$261.00
(was $250.35)
UBS
Allstate price target raised to $240 from $225 at Evercore ISI
$240.00
(was $250.59)
David Motemaden
·
Evercore ISI
Allstate price target raised to $242 from $236 at Cantor Fitzgerald
$242.00
(was $249.27)
Ryan Tunis
·
Cantor Fitzgerald
Allstate price target raised to $272 from $255 at Mizuho
$272.00
(was $251.17)
Mizuho Securities
Allstate price target raised to $213 from $203 at Barclays
$213.00
(was $248.37)
Alex Scott
·
Barclays
Allstate price target raised to $300 from $260 at Raymond James
$300.00
(was $248.04)
Raymond James
Allstate price target raised to $240 from $215 at Morgan Stanley
$240.00
(was $250.33)
Bob Huang
·
Morgan Stanley
HSBC Downgrades Allstate (ALL) to Hold
$264.00
(was $250.33)
Vikram Gandhi
·
HSBC
Allstate price target raised to $268 from $252 at Piper Sandler
$268.00
(was $217.26)
Piper Sandler
Raymond James Notes on Allstate (ALL) from Conference
$260.00
(was $213.61)
Gregory Peters
·
Raymond James